Business
Adia Labs Secures FDA Registration for Adia Vita, Expands Regenerative Medicine Nationwide
Winter Park, Florida--(Newsfile Corp. - March 3, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new subsidiary, Adia Labs LLC: the FDA has accepted the registration of Adia Vita. This acceptance reflects Adia Labs' notification to the FDA that it will be storing and distributing its premier stem cell product, Adia Vita, to doctors and clinics nationwide, broadening access to cutting-edge regenerative ...
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"Winter Park, Florida--(Newsfile Corp. - March 3, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new subsidiary, Adia Labs LLC: the FDA has accepted the registration of Adia Vita. This acceptance reflects Adia Labs' notification to the FDA that it will be storing and distributing its premier stem cell product, Adia Vita, to doctors and clinics nationwide, broadening access to cutting-edge regenerative medicine and significantly increasing revenue potential.","length":547,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":293,"url":"https://media.zenfs.com/en/newsfile_64/aff5e48d898b691229573eeaaba2149b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dDq51WGimeTg1K..Q2QX.w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUxMTtjZj13ZWJw/https://media.zenfs.com/en/newsfile_64/aff5e48d898b691229573eeaaba2149b","width":550,"height":293}},"href":"https://images.newsfilecorp.com/files/10520/242494_adia1.jpg","hrefExternal":true},{"type":"text","content":"To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/242494_adia1.jpg","length":119,"tagName":"p","attribs":{}},{"type":"text","content":"Adia Labs is thrilled to introduce Adia Vita, a top-tier product featuring umbilical cord stem cells with a minimum of 100 million viable cells and 3 trillion exosomes per unit. For people unfamiliar with regenerative medicine, stem cell therapies-such as those provided by Adia Med-usually cost between $15,000 and $35,000 per treatment because of their cutting-edge technology and life-changing benefits. However, Adia Med stands out by offering a superior product at a reduced price, driving rapid client growth and making these therapies more accessible. With the FDA's acceptance of this registration, Adia Labs is poised to bring Adia Vita nationwide, supporting clinical research and delivering therapeutic options for a variety of health conditions.","length":761,"tagName":"p"},{"type":"text","content":""Registering Adia Vita with the FDA marks a game-changing moment for us," said Larry Powalisz, CEO of ADIA Nutrition. "We're deeply grateful to the FDA for their timely and cooperative ef...